CSL to lay off up to 15% of workforce, cut R&D costs and spin out vaccine unit Fierce Biotech CSL to Spin Off Seqirus, Cut Up to 15% of Staff in Sweeping Restructure – WSJ The Wall Street Journal CSL Shares Slump as Disappointing Profit Eclipses Spinoff Bloomberg.com CSL shares dive as biotech firm flags more than 3,000 job cuts — as it …
Read More »Tag Archives: RampD
Moderna, working through operating cost and R&D cuts, to sideline 10% of global workforce by year-end – Fierce Pharma
Moderna, working through operating cost and R&D cuts, to sideline 10% of global workforce by year-end Fierce Pharma Moderna to slash 10% of workforce as biotech cuts costs, Covid shot sales slow CNBC Moderna will lay off 10% of employees, Massachusetts-based company announces CBS News Vaccine maker Moderna cuts hundreds of jobs; CEO says ‘every effort’ made to avoid layoffs The Business Journals Moderna …
Read More »